"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to RNA. [ FAQ on what and how to ask] For non-RNA questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Ms. Kathleen P. Gallagher
Headquarter: 10578 Science Center Drive, Suite 125, San Diego, CA, United States, 92121
Industry: Biotechnology, Investment Track: -, Employees: -
Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company's development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. The company was incorporated in 2025 and is headquartered in San Diego, California.
My Watchlist
